(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMA CRISTALINA DA ASPACITARABINA

ArquivadaInvention PatentPCT · IL2021051144

Application data

Number

112023005091

Type

Invention Patent

Filing

09/20/2021

Publication

04/18/2023

PCT

IL2021051144

Progress at the INPI

  1. Filing09/20/21
  2. Publication04/18/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 09/20/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 12/17/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BIOSIGHT LTD.

IL

Inventors

M. S. (pessoa física)

IL

R. L. (pessoa física)

IL

S. T. (pessoa física)

IL

Technical data

Priority claims

US

63/080,808 · 09/21/2020

Abstract

FORMA CRISTALINA DA ASPACITARABINA. A presente invenção se refere a um novo polimorfo cristalino do ácido (S)-2-amino-4-((1-((2R,3S,4S,5R)-3,4-di-hidroxi-5-(hidroximetil)tetrai-hidrofuran-2-il)-2-oxo-1,2-di-hidropirimidin-4-il)-4-oxobutanoico (também conhecido como BST-236, Astarabina® ou aspacitarabina), processos de preparação do mesmo e usos dos mesmos para o tratamento de doenças neoplásicas.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

12/17/2024

RPI 2815

Arquivamento - Art. 33 da LPI

#11.1

10/01/2024

RPI 2804

Notificação de entrada na fase nacional - PCT

#1.3

04/18/2023

RPI 2728

Alteração de dados cadastrais

#1.1

03/28/2023

RPI 2725

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.